Yoko Tanaka

Angiotensin II–Induced Transactivation of Epidermal Growth Factor Receptor Regulates Fibronectin and Transforming Growth Factor-β Synthesis via Transcriptional and Posttranscriptional Mechanisms

Yasutaka Moriguchi, Hiroaki Matsubara, Yasukiyo Mori et al. · Circulation Research · 1999 · 120 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Increased vascular endothelial growth factor and vascular endothelial growth factor–c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage i non–small cell lung cancer

Yasuhiko Ohta, Hiroshi Nozawa, Yoko Tanaka et al. · Journal of Thoracic and Cardiovascular Surgery · 2000 · 106 citations · Full text

Medicine, Oncology, Pathology +15

Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol

Toshiya Inada, Charles M. Beasley, Yoko Tanaka et al. · International Clinical Psychopharmacology · 2003 · 70 citations

Medicine, Pharmacotherapy, Psychiatry +17

Stimulation of Lead Absorption by Vitamin D Administration

Connie M. Smith, Hector F. DeLuca, Yoko Tanaka et al. · Journal of Nutrition · 1978 · 59 citations

Agriculture, Nutrition, Nutritional Sciences +13

KRAS up-regulates the expression of miR-181a, miR-200c and miR-210 in a three-dimensional-specific manner in DLD-1 colorectal cancer cells.

Keiko Doi, Takahiro Fujimoto, Yoko Tanaka et al. · PubMed · 2012 · 53 citations

Medicine, Molecular Biology, Oncology +16